Abstract |
Vitamin D is a secosteroid hormone. Vitamin D receptors are present in the majority of body tissues. The manifestations of hypovitaminosis D - linked to dysfunction of target tissues - are various, including osteoporosis, cancer, tuberculosis, hypertension, multiple sclerosis, depression, dementia, sarcopenia, propensity to fall… The serum 25-hydroxyvitamin D threshold value to avoid these adverse health events is around 30 ng/mL. Only 15% of the elderly reach this target concentration. For the remaining 85% with no supplements, the severity of hypovitaminosis D appears to be a biomarker of chronic diseases and of frailty. Conversely, the supplementation for correction of hypovitaminosis D positively impacts bone and non-bone morbidities - such as risks of falls and fractures - and reduces the mortality rate. A daily intake of at least 800-1,000 IU supplemental vitamin D(3) per day is the key.
|
Authors | Cédric Annweiler, Jean-Claude Souberbielle, Anne-Marie Schott, Laure de Decker, Gilles Berrut, Olivier Beauchet |
Journal | Geriatrie et psychologie neuropsychiatrie du vieillissement
(Geriatr Psychol Neuropsychiatr Vieil)
Vol. 9
Issue 3
Pg. 259-67
(Sep 2011)
ISSN: 2115-8789 [Print] France |
Vernacular Title | Vitamine D chez la personne âgée : les 5 points à retenir. |
PMID | 21896429
(Publication Type: English Abstract, Journal Article, Review)
|
Chemical References |
|
Topics |
- Aged
- Aged, 80 and over
- Biomarkers
- Dietary Supplements
- Humans
- Nutrition Policy
- Nutritional Requirements
- Reference Values
- Vitamin D
(adverse effects, blood, metabolism)
- Vitamin D Deficiency
(physiopathology)
|